These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25051523)

  • 1. Skin allograft and vascularized composite allograft: potential for long-term efficacy in the context of lymphatic modulation.
    Rinkinen J; Selley R; Agarwal S; Loder S; Levi B
    J Burn Care Res; 2014; 35(5):355-61. PubMed ID: 25051523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Lymphatic Drainage With a Self-Designed Surgical Approach Prolongs the Vascularized Skin Allograft Survival in Rats.
    Pei J; Li Y; Chen C; Zhang X; Wang S; Song Y; Liu B; Su Y; Guo S
    Ann Plast Surg; 2018 Jan; 80(1):76-82. PubMed ID: 28930779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
    Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
    J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of human skin allografts in patients with immunosuppression.
    Wendt JR; Ulich T; Rao PN
    Plast Reconstr Surg; 2004 Apr; 113(5):1347-54. PubMed ID: 15060346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable mixed hematopoietic chimerism permits tolerance of vascularized composite allografts across a full major histocompatibility mismatch in swine.
    Mathes DW; Solari MG; Gazelle GS; Butler PE; Wu A; Nazzal A; Nielsen GP; Huang CA; Sachs DH; Lee WP; Randolph MA
    Transpl Int; 2014 Oct; 27(10):1086-96. PubMed ID: 24963743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
    Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
    Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability to determine tissue health is main indication of allograft use in intermediate extent burns.
    Fletcher JL; Cancio LC; Sinha I; Leung KP; Renz EM; Chan RK
    Burns; 2015 Dec; 41(8):1862-1867. PubMed ID: 26471053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Effect of Skin Allograft in Burn Treatment: Impact on Future Vascularized Composite Allotransplantation.
    Garza RM; Press BH; Tyan DB; Karanas YL; Lee GK
    J Burn Care Res; 2017; 38(3):169-173. PubMed ID: 27801681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory Strategies Directed Toward Tolerance of Vascularized Composite Allografts.
    Madariaga MLL; Shanmugarajah K; Michel SG; Villani V; Muraglia GM; Torabi R; Leonard DA; Randolph MA; Colvin RB; Yamada K; Madsen JC; Cetrulo CL; Sachs DH
    Transplantation; 2015 Aug; 99(8):1590-1597. PubMed ID: 25757218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of microskin autografts with overlaid selectively decellularized split-thickness porcine skin in the repair of deep burn wounds.
    Sun T; Han Y; Chai J; Yang H
    J Burn Care Res; 2011; 32(3):e67-73. PubMed ID: 21436718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker and surrogate development in vascularised composite allograft transplantation: Current progress and future challenges.
    Honeyman C; Stark H; Wang HC; Hester J; Issa F; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):711-717. PubMed ID: 33436335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
    Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
    Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective.
    Amin KR; Fildes JE
    Transpl Immunol; 2024 Jun; 84():102035. PubMed ID: 38518826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
    Gama AR; Ng ZY; Shanmugarajah K; Mastroianni M; Randolph MA; Lellouch AG; Kohn J; Cetrulo CL
    J Burn Care Res; 2020 Nov; 41(6):1172-1178. PubMed ID: 32352521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.